Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001214659-24-019181
Filing Date
2024-11-14
Accepted
2024-11-14 16:11:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENTMENT NO. 3 o10302414sc13ga3.htm SC 13G/A 43087
  Complete submission text file 0001214659-24-019181.txt   44835
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Subject) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: SC 13G/A | Act: 34 | File No.: 005-85256 | Film No.: 241462253
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 211 CONGRESS STREET 8TH FLOOR BOSTON MA 02110
Business Address 211 CONGRESS STREET 8TH FLOOR BOSTON MA 02110 617-912-4972
Invenomic Capital Management LP (Filed by) CIK: 0001769456 (see all company filings)

EIN.: 810795975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A